Illuminating Success in mRNA-Based Therapeutics
Advancing Innovation, Accelerating Delivery for Patient Impact
A private network for mRNA drug developers
designed by mRNA drug developers
With the dozens of mRNA-based vaccine candidates currently in the pre-clinical and clinical phases of development, it is evident that the mRNA-based vaccine technology is a promising tool for developing novel therapeutic and prophylactic vaccines against infectious diseases and cancer. However, the multifarious obstacles associated with the likes of safety, efficacy, CMC aspects and general lack of guidance hamper the translation of mRNA-based therapeutics from the bench to the bedside.
To address some of these challenges head-on, mRNA pioneers worldwide have created the mRNA-Based Therapeutics: Searchlight network. The networks’ sole purpose is to overcome critical challenges and bottlenecks in mRNA therapeutic and vaccine development to accelerate the delivery of therapies to patients.
At the heart of Searchlight, we believe that innovation does not happen in isolation. Through the exchange of experiences and best practices, the network solves pressing issues faster than in isolation, saving time and money while increasing confidence in decision-making.
Business critical conversations
Virtual cornerstone meetings
We facilitate, structured, discussion-driven, mRNA-focused quarterly meetings for member companies.
Each high-impact 90-minute meeting takes place virtually via Zoom. The meeting agenda is carefully curated and focused on the topics and critical challenges requested by Searchlight members.
Member companies are represented by one internal champion with strategic oversight over its mRNA program to ensure that each discussion is high-value, high-impact, and delivers tangible outputs for members to take back to their organization.
Innovation doesn’t happen in isolation
Searchlight makes meaningful progress
"Regulatory opinions for mRNA will take time to stabilize but I’d expect the scope of this network to play an important role in accelerating that, which will mean getting better drugs to patients faster."
"This network offers us the valuable chance to discuss the things that don't appear in scientific publications as well as the chance to regularly engage with a trusted group of peers and see how the areas you’re interested in are evolving and advancing outside your company"
"The collective brain power in the scientific community is much better than the individual and while each company has their own way of thinking, a network that shares knowledge can help find out-of-the-box solutions to the key bottlenecks we are all facing"
Network with the best in the field
Gain insider knowledge and insights from scientific advisors
Bowen Li
Assistant Professor
University of Toronto
Harris Makatsoris
Professor
King's College London
Zoltán Kis
Biotechnologist and Bioprocess Engineer & Lecturer
University of Sheffield
Membership brochure
For more information on what’s included as part of the mRNA-Based Therapeutics: Searchlight membership, please download the membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment
The Searchlight platform
Build meaningful relationships and gain value all year around
Instant messaging
Contact fellow members via the private or group chat features.
Member meetups
Come together with leaders throughout the community at virtual cornerstone meetings and in-person gatherings at Hanson Wade conferences.
On demand
Explore the library of business critical content and videos on demand via the thematic rooms and content channels.